Citation: D. Aarsland et al., CITALOPRAM PLUS MIANSERIN IN PATIENTS WITH PARKINSONS-DISEASE AND DEPRESSION - AN OPEN-LABEL STUDY, Nordic journal of psychiatry, 52(2), 1998, pp. 115-116
Citation: D. Aarsland et al., PREVALENCE AND CLINICAL CORRELATES OF PSYCHOSIS IN PARKINSONS-DISEASE- A COMMUNITY-BASED STUDY, Nordic journal of psychiatry, 51(2), 1997, pp. 93-93
Citation: D. Aarsland et al., THE RELATIONSHIP OF AGGRESSIVE-BEHAVIOR TO OTHER NEUROPSYCHIATRIC SYMPTOMS IN PATIENTS WITH ALZHEIMERS-DISEASE, Nordic journal of psychiatry, 50(2), 1996, pp. 101-101
Authors:
TANDBERG E
LARSEN JP
AARSLAND D
CUMMINGS JL
Citation: E. Tandberg et al., THE OCCURRENCE OF DEPRESSION IN PARKINSONS-DISEASE - A COMMUNITY-BASED STUDY, Archives of neurology, 53(2), 1996, pp. 175-179
Citation: D. Aarsland et al., RELATIONSHIP OF AGGRESSIVE-BEHAVIOR TO OTHER NEUROPSYCHIATRIC SYMPTOMS IN PATIENTS WITH ALZHEIMERS-DISEASE, The American journal of psychiatry, 153(2), 1996, pp. 243-247
Citation: K. Dickstein et al., PLASMA N-TERMINAL ATRIAL-NATRIURETIC-FACTOR IS PREDICTIVE OF MORTALITY IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Circulation, 92(8), 1995, pp. 2618-2618
Authors:
AARSLAND D
LARSEN JP
REINVANG I
AASLAND AM
Citation: D. Aarsland et al., EFFECTS OF CHOLINERGIC BLOCKADE ON LANGUAGE IN HEALTHY-YOUNG WOMEN - IMPLICATIONS FOR THE CHOLINERGIC HYPOTHESIS IN DEMENTIA OF THE ALZHEIMER-TYPE, Brain, 117, 1994, pp. 1377-1384